CLINICAL_TRIALS
trial_result
· 2019-06-03
Clinical Trial Update: QVA Mechanistic Efficacy Study (Receptor Effects, Etc) [Phase 4]
Summary
Phase 4 trial evaluating mechanistic efficacy and receptor effects in COPD; results completed with posted data in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED | Results posted: 2019-06-03